Phase IV study of long term Peg-Intron [peginterferon-alfa-2b] for patients who have failed to respond to Rebetron [peginterferon-alfa-2b/ribavirin/interferon] with advanced fibrosis and cirrhosis secondary to hepatitis C- The Copilot Trial.
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Colchicine
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms COPILOT
- 17 Apr 2008 Final results will be presented at the European Association for the Study of the Liver 43rd annual meeting in April 2008.
- 17 Apr 2008 Status changed from in progress to completed, as reported by Schering-Plough.
- 23 Jun 2007 Status changed from recruiting to in progress.